Blood | American Society of Hematology

Skip Nav Destination

Current Issue

Volume 145,

Issue 17,

April 24 2025

View This Issue

Issue Highlights

Assessment of genetic variants in thrombomodulin
Glucarpidase for treatment of high-dose methotrexate toxicity
PSTK inhibition activates cGAS-STING and ferroptosis in AML
Preventing SCD cardiomyopathy due to unresolved inflammation
APOE variant status and transplant outcome in AML
Perspective: CAR T cells to treat autoimmune disorders
Spotlight: biomarkers for CD3×CD20 bispecific antibodies

Latest in Blood

Free Articles

Nonleukemic T/B mixed phenotype acute leukemia with PHF6 and NOTCH1 mutations

Oscar Silva; Allison Shaw

https://doi.org/10.1182/blood.2021012538

View All Free Articles

Plenary Papers

Genetic iron overload aggravates, and pharmacological iron restriction improves, MDS pathophysiology in a preclinical study

Ada Antypiuk; S. Zebulon Vance; Richa Sharma; Sara Passos; Michela Asperti; Shobana Navaneethabalakrishan; Franz Dürrenberger; Vania Manolova; Francesca Vinchi

https://doi.org/10.1182/blood.2024026135

View All Plenary Papers

First Edition

A phase 2 randomized study of modakafusp alfa as a single agent in patients with relapsed/refractory multiple myeloma

Sarah A Holstein; Shebli Atrash; Hira Mian; Meletios Athanasios Dimopoulos; Fredrik Schjesvold; Rakesh Popat; Nishi Shah; Moshe E Gatt; Christian B. Gocke; Laurent Frenzel; Cyrille Touzeau; Meral Beksac; Salomon Manier; Hila Magen; Patrick Travis; Omar Nadeem; Kaveri Suryanarayan; Cheryl Li; Shuli Li; Allison Nelson; Dasha Cherepanov; Xavier Parot; Dan T Vogl

https://doi.org/10.1182/blood.2024027873

View All First Edition Articles

Clinical Trials and Observations

A phase 2 randomized study of modakafusp alfa as a single agent in patients with relapsed/refractory multiple myeloma

https://doi.org/10.1182/blood.2024027873

View All Clinical Trials and Observations

Advertisement intended for health care professionals

2024 Blood Cover Art Contest Winner
Year in review: Blood's ten most read articles published in 2024

170,000 citations
earned in 2023

Acknowledgement of Reviewers for 2024

Featured Content

Phosphoseryl-tRNA kinase inhibition in acute myeloid leukemia (AML), APOE gene variants and post-hematopoietic stem cell transplant outcomes in AML, and the role of chronic inflammation in sickle cell cardiomyopathy

Issue Highlights

170,000 citations
earned in 2023

Featured Content

Phosphoseryl-tRNA kinase inhibition in acute myeloid leukemia (AML), APOE gene variants and post-hematopoietic stem cell transplant outcomes in AML, and the role of chronic inflammation in sickle cell cardiomyopathy

PSTK inhibition activates cGAS-STING, precipitating ferroptotic cell death in leukemic stem cells

Common hereditary variants of the APOE gene and posttransplant outcome in acute myeloid leukemia

17(R)-Resolvin D1 protects against sickle cell–related inflammatory cardiomyopathy in humanized mice

Functional assessment of genetic variants in thrombomodulin detected in patients with bleeding and thrombosis

Glucarpidase for treatment of high-dose methotrexate toxicity

ASH Publications

American Society of Hematology

Issue Highlights

170,000 citations earned in 2023

Featured Content

Phosphoseryl-tRNA kinase inhibition in acute myeloid leukemia (AML), APOE gene variants and post-hematopoietic stem cell transplant outcomes in AML, and the role of chronic inflammation in sickle cell cardiomyopathy

PSTK inhibition activates cGAS-STING, precipitating ferroptotic cell death in leukemic stem cells

Common hereditary variants of the APOE gene and posttransplant outcome in acute myeloid leukemia

17(R)-Resolvin D1 protects against sickle cell–related inflammatory cardiomyopathy in humanized mice

Functional assessment of genetic variants in thrombomodulin detected in patients with bleeding and thrombosis

Glucarpidase for treatment of high-dose methotrexate toxicity

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only

170,000 citations
earned in 2023